– 2010
/
(SAGE)
(SAGE) 1
. . 2010 / 15 13
:
.(SAGE)
(SAGE)
– 2010 . 2015 .
(1 :
.
2010 .
.
1
http://www.who.int/immunization/sage/en/index.html, accessed May 2010).(
1
(2 . ( .( . ( ) ) )
(SAGE)
) 2010 .(
/ 2015
/ .2010 /
. . 2010
.
2010 .(SAGE) . .
/
26
2
(SAGE)
.
5 . (SAGE) .
.
strain
.
replacement
GAVI
. . .
. ) 3
(ProVac
2
. 2009 3
15 (SAGE)
2010
/
Vaccine
. . .
: .2010 ( 2011 . 58 72 )
2009
/ (AMC)
1500 .
.
2
Andrus JK et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Reports, 2007, 122:811–816.
Nelson EAS et al. The role of national advisory committees in supporting evidence-based decision making for national immunisation programs. Vaccine, 2010, 28(Suppl. 1):A1–110 (also available from http://www.sciencedirect.com/science/issue/5188-2010-999719999.8998-1900719).
3
4
2010 Pfizer GlaxoSmithKline
/
/ .2013 / . (SAGE)
10≥ 10≥ 2010 /
30 30 2012
. .
2015
2011
) (DTP3) %70 . (
. ) 2015
2.6
2015 2010
(B
–B 5
41 ) [HPV] 4.2
47
18
(A . .2010
(2 . (3 .
(1 : . .
5 7.5 . 2008 %92 2009 2000 .2010 . 6
.
10
%75
2008
: .
.
(1 : (3 .2008 " (4 . (6 . (5 . . " (2 .
. .
(1 : (2 . . (3 .
7
. ) .( .
2009
. .
2008
. 13 7 . 4 .
2010
/
24
.
8
(SAGE) . .
(SAGE)
.
(SAGE)
. .
(AEFI)
" .
" .
. . 9
. ) .(
.
.
.
(SAGE)
.
10
(SAGE)
. .
GACVS 4
2009
/
(SAGE) . 52010 (PCV)1 (
/
25
GACVS DNA )
.
(SAGE) DNA
(PCV)1 PCV1 DNA
.Rotarix
5
36-29 ،2010 ،5 ر ا Global Advisory Committee on Vaccine Safety. Statement of the Global Advisory Committee on Vaccine Safety on Rotarix. Geneva, World Health Organization, 2010 , accessed http://www.who.int/vaccine_safety/topics/rotavirus/rotarix_statement_march_2010/en/index.html( May 2010).
4
11
(
50000 .(
) 60 )
(SAGE) GACVS Rotarix . .76 .
5 .
124 34 .( %64
. 90 ) . 106
6 7
ر ر
ا. 51/52, 2009, . 533–537. ا. 32, 2007, . 285–296.
12
. 8 2005 . . . . 2011 /
.
.
.9
(SAGE)
.
.
PATH
Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies Geneva, World Health Organization, 2006 (WHO/IVB/05.19). (Also available at http://www.who.int/immunization/documents/WHO_IVB_05.19/en/index.html.) 9 إ/ن 15 – 13 ا ة ا ا ري ا ا اء ا ا ع، ت وا اد ا وا ا .2010 ، ا ا .ا ، ،2010 (http://www.who.int/immunization/sage/previous_april2010/en/index1.html, accessed May 2010).
8
13
Health Systems Building Blocks
. 244 .
. . .
.
(SAGE
)
.
14
. ) B DTP [Hib] ) .( ( HPV ) : ( )
. . (SAGE ) .
(
)
. 2009 .10 /
(SAGE ) (SAGE )
10
532-517
،2009 ،50 ر
ا
15
. 24 . 12
. 6 . . 6
6≤
.
. . . .
. 16
. (SAGE ) ( ) . .
3 ≤ . . . (SAGE ) : .
.
17
) (cocooning (SAGE ) .
(SAGE )
. .
. . (SAGE ) .
B
(SAGE ) . . 18
( (SAGE ) . .( )
)
RV144
rpg120 CRF-01E B
( .
) 11
1
.
: (2 .
. . intercurrent infections .
16395 (1 CD4+ T
125 (P=0.039)
%31.2 .
.
(74) . CD4+ T
51
11
11 Rerks-Ngarm S et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine, 2009, 361:2209–2220. (Also available from http://content.nejm.org/cgi/content/full/NEJMoa0908492.)
19
. . .( %99 %33) CD4+ T
(1 ≥) (3 . ( 12 (2 . %60
.
RV144 . (SAGE ) .
21
20
/
.2010
/
23 .2010
(SAGE ) . . . .
(SAGE ) .2009 289 A(H1N1) H5N1
A(H5N1) 500 2009 (H1N1) 15 2003 / . . .
B
(SAGE ) .2990 م (H1N1)
21
. < .
350 <
570
.12% 70
1.37 %28 : .2009 /
2010 2010 /
/
.
2009 -(H1N1)
. / . 94 12
2010
Wood DJ, et al. Update on H1N1 vaccine immunogenicity, safety and effectiveness. Geneva, World Health Organization, 2010 (http://www.who.int/immunization/sage/Influenza_2_H1N1_vaccine_immunogenicity_D_Wood_SAGE_April_201 0.pdf,; accessed May 2010).
22
. .2010 . /
48 46 22
74
(SAGE ) 500000 250000 . .13 . ) 56.19 ( . ( %75 ) 2011 /
H1N1 .2010 / (SAGE ) . 13
(SAGE )
(SAGE )
Shindo N. Global seasonal influenza disease burden and implementation of WHA 56.19. Geneva, World Health Organization, 2010 (http://www.who.int/immunization/sage/Influenza_4_WHA56.19_N_Shindo_SAGE_April_2010.pdf, accessed May 2010).
23
H1N1 (SAGE ) H5N1 / .H1N1 .2010
(SAGE )
.
(SAGE ) . . (GRADE) (GRADE) . 24
2008
(GRADE) . (GRADE) .
. (SAGE )
.
GRADE )
(SAGE )
( . . . . GRADE
25
(SAGE ) GRADE
. . Bradford-Hill
(SAGE ) . .GRADE
(SAGE )
2015 .
2010
26
(SAGE )
.
.
(SAGE ) . . (1 : .( 6 ) 3 (2 (3 . 2012 2010
(4 . .
27
2010 . . 6
.
(SAGE )
. 1.4 .2012 2010
.
28
(SAGE ) 14
.2010
/
Polio vaccines and routine polio immunization in the pre-eradication era [draft]. Geneva, World Health Organization, 2010 (http://www.who.int/immunization/sage/WHO_position_paper_on_polio_vaccines__Draft_2_March_2010.pdf, accessed May 2010).
14
29